fda compounding semaglutide crackdown news today 2025 proposes a new GLP-1 How GLP-1 weight loss compounders

Editorial Advisory Board Member, Harvard Health Publishing GLP-1 drugs for diabetes and weight loss have proven to be very effective, but they do have side effects

Any use outside of a regulated clinical trial setting carries significant and unpredictable risks

Slightly less interest in snacking between meals

In 2024, according to GoodRx, out-of-pocket cost for the most common injectable weight loss medications (Zepbound, Saxenda, Wegovy, and Ozempic) averaged from $950 to $2,000 USD per month

To maximize efficacy while minimizing side effects, a common dose escalation regimen in metabolic studies is as follows: Weeks 14: 2 mg weekly (to reduce gastrointestinal side effects) Weeks 58: 4 mg weekly Weeks 912: 8 mg weekly Week 13 onward: 12 mg weekly for optimal results Beyond these metabolic effects, retatrutide is paving the way for exciting advances in tissue repair research

Retinal disorders in people with type 2 diabetes